Septerna (SEPN) Retained Earnings (2023 - 2026)
Septerna (SEPN) posted quarterly Retained Earnings of -$175.9 million for Q1 2026, down 88933.33% year-over-year from N/an in Q1 2025, and down 28607.29% quarter-over-quarter from $617000.0 in Q4 2025.
Septerna (SEPN) Retained Earnings (2023 - 2026) Analysis & Trends
Septerna's Retained Earnings history runs 4 years deep, the most recent figure standing at -$175.9 million for Q1 2026.
- In Q1 2026, Retained Earnings fell 88933.33% year-over-year to -$175.9 million; the TTM figure through Mar 2026 stood at -$175.9 million (down 88933.33% YoY), while the FY2025 annual figure was $617000.0, up 1001.79% from the prior year.
- Retained Earnings for Q1 2026 stood at -$175.9 million, down from $617000.0 in the prior quarter.
- The five-year high for Retained Earnings was $617000.0 in Q4 2025, with the low at -$175.9 million in Q1 2026.
- The 4-year median for Retained Earnings is -$23.3 million (2023), against an average of -$67.8 million.
- Peak annual rise in Retained Earnings reached 1001.79% in 2025, while the deepest fall reached 89028.98% in 2025.
- Septerna's Retained Earnings stood at -$46.6 million in 2023, then soared by 100.12% to $56000.0 in 2024, then surged by 1001.79% to $617000.0 in 2025, then slumped by 28607.29% to -$175.9 million in 2026.
- Business Quant data shows SEPN's Retained Earnings at -$175.9 million in Q1 2026, $617000.0 in Q4 2025, and -$156.5 million in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Retained Earnings (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 128.13 Bn | 120.28 Bn | 2.84 Bn | 15.69 Bn |
| 2 | Regeneron Pharmaceuticals | 112.33 Bn | 104.33 Bn | 3.93 Bn | 37.62 Bn |
| 3 | Argenx Se | 53.24 Bn | 48.05 Bn | 1.41 Bn | 1.41 Bn |
| 4 | Revolution Medicines | 43.64 Bn | 43.64 Bn | - | -4.00 Bn |
| 5 | BeOne Medicines | 39.27 Bn | 34.17 Bn | 1.53 Bn | 13.05 Bn |
| 6 | MindWalk Holdings | 35.32 Bn | 35.31 Bn | 1.82 Bn | -104.13 Mn |
| 7 | Royalty Pharma | 33.72 Bn | 35.84 Bn | - | 4.38 Bn |
| 8 | Alnylam Pharmaceuticals | 30.58 Bn | 27.27 Bn | 992.69 Mn | -6.33 Bn |
| 9 | Insmed | 27.01 Bn | 25.85 Bn | 358.27 Mn | 6.57 Bn |
| 10 | Septerna | 2.08 Bn | 2.08 Bn | - | -188.92 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | -188.92 Mn |
| Mar 31, 2026 | -175.89 Mn |
| Dec 31, 2025 | 617,000.00 |
| Sep 30, 2025 | -156.52 Mn |
| Jun 30, 2025 | -164.70 Mn |
| Mar 31, 2025 | 198,000.00 |
| Dec 31, 2024 | 56,000.00 |
| Sep 30, 2024 | 176,000.00 |
| Dec 31, 2023 | -46.58 Mn |